Mr. Nazim Nadvee Haider
Senior Manager, Commercial Insights & Analytics, Pliant Therapeutics, San Francisco, CA, USA
LinkedIn
As a seasoned professional with over ten years of experience across consulting, healthcare, startup, and manufacturing industries, he has contributed significantly to commercial analytics and forecasting in the pharmaceutical industry, particularly in rare disease management. Currently, he leads the Commercial Insights & Analytics capability at Pliant Therapeutics, supporting rare disease pipeline indications and collaborating with clinical, research, and investor relation teams.
What He Brings to the Table
With a strong background in commercial analytics and forecasting, he brings a wealth of expertise to strengthen the understanding of rare disease markets and patient journeys. His collaboration with clinical teams, evidence and insights generation, and support for clinical drug development has been pivotal in driving strategic decision-making processes within the pharmaceutical industry.
Something About His Background
His experience spans multiple fields in the pharmaceutical industry, including commercial analytics, forecasting, and strategic planning for rare disease management. He holds an MBA from Babson College and a Mechanical Engineering degree from Manipal Institute of Technology, India.
A Highlight from His Career
He has been instrumental in providing insights and driving strategies for rare disease pipeline indications, collaborating with clinical, research, and investor relation teams to support phase 2 and 3 of clinical drug development.
What He Commits to as a Professional
He is committed to delivering innovative solutions, driving strategic decision-making processes, and contributing to the advancements in commercial analytics and forecasting within the pharmaceutical industry.
Proficiency
- Commercial analytics and forecasting
- Rare disease management
- Strategic decision-making
- Clinical drug development support
Demonstrated Professional/Academic Excellence
- Leadership in commercial insights and analytics at Pliant Therapeutics
- Contributions to strategic decision-making in rare disease management
His vision is to continue driving advancements in commercial analytics and forecasting within the pharmaceutical industry, contributing to rare disease management, and collaborating with clinical and research teams to drive impactful outcomes for patient care.
JRTCSE is proud to include Mr. Nazim Nadvee Haider as a distinguished member of our prestigious editorial review board.
